MannKind | MNKD - Stock

Aktienkurs
2.50
Täglich Wechseln
-0.11 -4.06%
Monatlich
-54.80%
Jährlich
-52.40%
Q1 Prognose
2.69




Stock Veränderung Datum
Adma Biologics USD 206.46M 9.8M 2025-12
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Insmed USD 132.07M 11.1M 2025-12
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
MacroGenics USD 7.91M 840K 2025-12
MannKind USD 35.31M 8.34M 2025-12
Merck USD 6.44B 157M 2025-09
Novavax USD 11.54M 1.97M 2025-12
Novo Nordisk DKK 42.85B 2B 2025-03
Pfizer USD 11.47B 201M 2025-09
Sanofi EUR 22.69B 1.81B 2025-12